Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
- DOI
- 10.1016/s2468-1253(23)00318-7
- Published
- 2024-02
- Container
- The Lancet Gastroenterology & Hepatology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s2468-1253-23-00318-7,
title = {Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial},
author = {Silvio Danese and Remo Panaccione and Brian G Feagan and Anita Afzali and David T Rubin and Bruce E Sands and Walter Reinisch and Julián Panés and Aparna Sahoo and Natalie A Terry and Daphne Chan and Chenglong Han and Mary Ellen Frustaci and Zijiang Yang and William J Sandborn and Tadakazu Hisamatsu and Jane M Andrews and Geert R D'Haens and Oleksandr Oliinyk and Leonid Bilianskyi and Jadwiga Gniady-Jastrzebska and Robert Petryka and Tomasz Arlukowicz and Piotr Gietka and Marcin Zmudzinski and Syed Mumtaz and Douglas Wolf and Katarzyna Wojcik and George Duvall and Monika Augustyn and Rafal Filip and Dino Tarabar and Alexander Tkachev and Ursula Seidler and Eran Zittan and Juris Pokrotnieks and Oksana Shchukina and Andro Machavariani and Laura Loy and Niazy Abu-farsakh and Pesegova Marina and Slobodan Sreckovic and Martin Laclav and Shu-Chen Wei and Daniel Suiter and Aleksey Borsuk and Xavier Hebuterne and Carsten Buning and Adi Lahat-Zok and Wit Danilkiewicz and Bernadetta Frysna and Ivana Jovicic and Olena Datsenko and Maninder Guram and Animesh Jain and Zahid Rashid and Sonja Heeren and Natallia Shulga and Ivan Timkin and Srdjan Gornjakovic and Milan Lukas and Romain Altwegg and Ariadne Desjeux and Jean-Marie Reimund and Manana Giorgadze and Christoph Jochum and Hiroaki Ito and Katsuhiko Nakai and Tomohisa Takagi and Osamu Zaha and Changhwan Choi and Taeoh Kim and Jonghun Lee and Ieva Stundiene and Ida Normiha Hilmi and Rosaida Hj Md Said and Jaroslaw Leszczyszyn and Diana Abdulganieva and Yulia Fominykh and Svetlana Maksyashina and Jozef Balaz and Manuel Van Domselaar and Taylan Kav and Patrick Dennis and Patricia Henry and Robert Holmes and Christopher Johnson and Matthew McBride and Harry Sarles and Gregory Moore and Ruslan Yakubtsevich and Vinciane Muls and Stevan Trbojevic and Waqqas Afif and Charles Bernstein and Ivo Klarin and Zuzana Serclova and Miroslava Volfova and Pierre Desreumaux and Cyrielle Gilletta de Saint Joseph and Xavier Roblin and Lucine Vuitton and Kakhaber Chelidze and Tanja Kuehbacher and Ioannis Koutroubakis and Michele Cicala and Walter Fries and Antonio Gasbarrini and Nobuo Aoyama and Yoshito Hayashi and Fumihito Hirai and Norkiyuki Horiki and Namiko Hoshi and Tomoki Inaba and Ishida Hiroyasu and Atsuo Maemoto and Takayuki Matsumoto and Kayoko Matsushima and Satoshi Motoya and Masaki Taruishi and Mohammed Rashid and Jaeyoung Chun and Young-Ho Kim and Dong Il Park and Ala Sharara and Laimas Jonaitis and Gjorgi Deriban and James Brooker and Beata Gawdis-Wojnarska and Barbara Wozniak-Stolarska and Pavel Andreev and Vladimir Simanenkov and Vasiliy Trofimov and Igor Jovanovic and Natasa Zdravkovic and Xavier Aldeguer i Mante and Vicent Hernandez Ramirez and Hale Akpinar and Gurkan Celebi and Hulya Hamzaoglu and Juan Fernandez and Jayaprakash Kamath and Nicole Palekar and Jatinder S. Pruthi and David Rausher and Timothy Ritter},
year = {2024},
journal = {The Lancet Gastroenterology \& Hepatology},
doi = {10.1016/s2468-1253(23)00318-7},
url = {https://doi.org/10.1016/s2468-1253(23)00318-7}
}RIS
TY - JOUR TI - Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial AU - Silvio Danese AU - Remo Panaccione AU - Brian G Feagan AU - Anita Afzali AU - David T Rubin AU - Bruce E Sands AU - Walter Reinisch AU - Julián Panés AU - Aparna Sahoo AU - Natalie A Terry AU - Daphne Chan AU - Chenglong Han AU - Mary Ellen Frustaci AU - Zijiang Yang AU - William J Sandborn AU - Tadakazu Hisamatsu AU - Jane M Andrews AU - Geert R D'Haens AU - Oleksandr Oliinyk AU - Leonid Bilianskyi AU - Jadwiga Gniady-Jastrzebska AU - Robert Petryka AU - Tomasz Arlukowicz AU - Piotr Gietka AU - Marcin Zmudzinski AU - Syed Mumtaz AU - Douglas Wolf AU - Katarzyna Wojcik AU - George Duvall AU - Monika Augustyn AU - Rafal Filip AU - Dino Tarabar AU - Alexander Tkachev AU - Ursula Seidler AU - Eran Zittan AU - Juris Pokrotnieks AU - Oksana Shchukina AU - Andro Machavariani AU - Laura Loy AU - Niazy Abu-farsakh AU - Pesegova Marina AU - Slobodan Sreckovic AU - Martin Laclav AU - Shu-Chen Wei AU - Daniel Suiter AU - Aleksey Borsuk AU - Xavier Hebuterne AU - Carsten Buning AU - Adi Lahat-Zok AU - Wit Danilkiewicz AU - Bernadetta Frysna AU - Ivana Jovicic AU - Olena Datsenko AU - Maninder Guram AU - Animesh Jain AU - Zahid Rashid AU - Sonja Heeren AU - Natallia Shulga AU - Ivan Timkin AU - Srdjan Gornjakovic AU - Milan Lukas AU - Romain Altwegg AU - Ariadne Desjeux AU - Jean-Marie Reimund AU - Manana Giorgadze AU - Christoph Jochum AU - Hiroaki Ito AU - Katsuhiko Nakai AU - Tomohisa Takagi AU - Osamu Zaha AU - Changhwan Choi AU - Taeoh Kim AU - Jonghun Lee AU - Ieva Stundiene AU - Ida Normiha Hilmi AU - Rosaida Hj Md Said AU - Jaroslaw Leszczyszyn AU - Diana Abdulganieva AU - Yulia Fominykh AU - Svetlana Maksyashina AU - Jozef Balaz AU - Manuel Van Domselaar AU - Taylan Kav AU - Patrick Dennis AU - Patricia Henry AU - Robert Holmes AU - Christopher Johnson AU - Matthew McBride AU - Harry Sarles AU - Gregory Moore AU - Ruslan Yakubtsevich AU - Vinciane Muls AU - Stevan Trbojevic AU - Waqqas Afif AU - Charles Bernstein AU - Ivo Klarin AU - Zuzana Serclova AU - Miroslava Volfova AU - Pierre Desreumaux AU - Cyrielle Gilletta de Saint Joseph AU - Xavier Roblin AU - Lucine Vuitton AU - Kakhaber Chelidze AU - Tanja Kuehbacher AU - Ioannis Koutroubakis AU - Michele Cicala AU - Walter Fries AU - Antonio Gasbarrini AU - Nobuo Aoyama AU - Yoshito Hayashi AU - Fumihito Hirai AU - Norkiyuki Horiki AU - Namiko Hoshi AU - Tomoki Inaba AU - Ishida Hiroyasu AU - Atsuo Maemoto AU - Takayuki Matsumoto AU - Kayoko Matsushima AU - Satoshi Motoya AU - Masaki Taruishi AU - Mohammed Rashid AU - Jaeyoung Chun AU - Young-Ho Kim AU - Dong Il Park AU - Ala Sharara AU - Laimas Jonaitis AU - Gjorgi Deriban AU - James Brooker AU - Beata Gawdis-Wojnarska AU - Barbara Wozniak-Stolarska AU - Pavel Andreev AU - Vladimir Simanenkov AU - Vasiliy Trofimov AU - Igor Jovanovic AU - Natasa Zdravkovic AU - Xavier Aldeguer i Mante AU - Vicent Hernandez Ramirez AU - Hale Akpinar AU - Gurkan Celebi AU - Hulya Hamzaoglu AU - Juan Fernandez AU - Jayaprakash Kamath AU - Nicole Palekar AU - Jatinder S. Pruthi AU - David Rausher AU - Timothy Ritter PY - 2024 JO - The Lancet Gastroenterology & Hepatology DO - 10.1016/s2468-1253(23)00318-7 UR - https://doi.org/10.1016/s2468-1253(23)00318-7 ER -
APA
Danese, S., Panaccione, R., Feagan, B. G., Afzali, A., Rubin, D. T., Sands, B. E., Reinisch, W., Panés, J., Sahoo, A., Terry, N. A., Chan, D., Han, C., Frustaci, M. E., Yang, Z., Sandborn, W. J., Hisamatsu, T., Andrews, J. M., D'Haens, G. R., Oliinyk, O., Bilianskyi, L., Gniady-Jastrzebska, J., Petryka, R., Arlukowicz, T., Gietka, P., Zmudzinski, M., Mumtaz, S., Wolf, D., Wojcik, K., Duvall, G., Augustyn, M., Filip, R., Tarabar, D., Tkachev, A., Seidler, U., Zittan, E., Pokrotnieks, J., Shchukina, O., Machavariani, A., Loy, L., Abu-farsakh, N., Marina, P., Sreckovic, S., Laclav, M., Wei, S., Suiter, D., Borsuk, A., Hebuterne, X., Buning, C., Lahat-Zok, A., Danilkiewicz, W., Frysna, B., Jovicic, I., Datsenko, O., Guram, M., Jain, A., Rashid, Z., Heeren, S., Shulga, N., Timkin, I., Gornjakovic, S., Lukas, M., Altwegg, R., Desjeux, A., Reimund, J., Giorgadze, M., Jochum, C., Ito, H., Nakai, K., Takagi, T., Zaha, O., Choi, C., Kim, T., Lee, J., Stundiene, I., Hilmi, I. N., Said, R. H. M., Leszczyszyn, J., Abdulganieva, D., Fominykh, Y., Maksyashina, S., Balaz, J., Domselaar, M. V., Kav, T., Dennis, P., Henry, P., Holmes, R., Johnson, C., McBride, M., Sarles, H., Moore, G., Yakubtsevich, R., Muls, V., Trbojevic, S., Afif, W., Bernstein, C., Klarin, I., Serclova, Z., Volfova, M., Desreumaux, P., Joseph, C. G. D. S., Roblin, X., Vuitton, L., Chelidze, K., Kuehbacher, T., Koutroubakis, I., Cicala, M., Fries, W., Gasbarrini, A., Aoyama, N., Hayashi, Y., Hirai, F., Horiki, N., Hoshi, N., Inaba, T., Hiroyasu, I., Maemoto, A., Matsumoto, T., Matsushima, K., Motoya, S., Taruishi, M., Rashid, M., Chun, J., Kim, Y., Park, D. I., Sharara, A., Jonaitis, L., Deriban, G., Brooker, J., Gawdis-Wojnarska, B., Wozniak-Stolarska, B., Andreev, P., Simanenkov, V., Trofimov, V., Jovanovic, I., Zdravkovic, N., Mante, X. A. I., Ramirez, V. H., Akpinar, H., Celebi, G., Hamzaoglu, H., Fernandez, J., Kamath, J., Palekar, N., Pruthi, J. S., Rausher, D., & Ritter, T. (2024). Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(23)00318-7
Source records
- crossref · retrieved 2026-09-26T20:24:06.718Z